DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
TECHNETIUM PENTETATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
TECHNETIUM PENTETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C14H18N3NaO10Tc
Molecular Weight:
509.3
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DOMIPHEN
4
Small molecule
Approved
Unknown
Unknown
Infections
Unknown
DOMIPHEN
×
Maximum Phase:
4
First Approval:
None
UNII:
4AZL56CU0F
Molecule Type:
Small molecule
Molecular Formula:
C22H40NO+
Molecular Weight:
334.57
AlogP:
6.06
PSA:
9.23
HBD:
0.0
HBA:
#RotB:
15.0
Source:
LIDOFLAZINE
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
LIDOFLAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
J4ZHN3HBTE
Molecule Type:
Small molecule
Molecular Formula:
C30H35F2N3O
Molecular Weight:
491.63
AlogP:
5.75
PSA:
35.58
HBD:
1.0
HBA:
#RotB:
9.0
Source:
HYOSCYAMINE
4
Small molecule
Approved
Unknown
Unknown
Digestive System Diseases
Unknown
HYOSCYAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
PX44XO846X
Molecule Type:
Small molecule
Molecular Formula:
C17H23NO3
Molecular Weight:
289.37
AlogP:
1.93
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
4.0
Source:
INSULIN DETEMIR RECOMBINANT
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
INSULIN DETEMIR RECOMBINANT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IODOHIPPURATE SODIUM I 131
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
IODOHIPPURATE SODIUM I 131
×
Maximum Phase:
4
First Approval:
None
UNII:
9BRV734R3E
Molecule Type:
Small molecule
Molecular Formula:
C9H7INNaO3
Molecular Weight:
331.06
AlogP:
1.11
PSA:
66.4
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TACALCITOL
4
Small molecule
Approved
Unknown
Unknown
Psoriasis
Unknown
TACALCITOL
×
Maximum Phase:
4
First Approval:
None
UNII:
C2W72OJ5ZU
Molecule Type:
Small molecule
Molecular Formula:
C27H44O3
Molecular Weight:
416.65
AlogP:
5.56
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
6.0
Source:
TRASTUZUMAB-DKST
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TRASTUZUMAB-DKST
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIPHENHYDRAMINE CITRATE; IBUPROFEN
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
DIPHENHYDRAMINE CITRATE; IBUPROFEN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARTEMISININ
4
Small molecule
Approved
Unknown
Unknown
Severe Acute Respiratory Syndrome; Schizophrenia; Malaria
Unknown
ARTEMISININ
×
Maximum Phase:
4
First Approval:
None
UNII:
9RMU91N5K2
Molecule Type:
Small molecule
Molecular Formula:
C15H22O5
Molecular Weight:
282.34
AlogP:
2.39
PSA:
53.99
HBD:
0.0
HBA:
#RotB:
0.0
Source:
CEFTAROLINE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
CEFTAROLINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INSULIN DEGLUDEC; LIRAGLUTIDE
4
Combination
Approved
Unknown
SUBCUTANEOUS
Unknown
Unknown
INSULIN DEGLUDEC; LIRAGLUTIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEPROTUMUMAB-TRBW
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TEPROTUMUMAB-TRBW
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IRON DEXTRAN
4
Unknown
Approved
OTHER
INJECTION
Pregnancy; Anemia; Anemia, Iron-Deficiency; Folic Acid Deficiency
Unknown
IRON DEXTRAN
×
Maximum Phase:
4
First Approval:
None
UNII:
95HR524N2M
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ASPIRIN; CAFFEINE; ORPHENADRINE CITRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRICLOCARBAN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
TRICLOCARBAN
×
Maximum Phase:
4
First Approval:
None
UNII:
BGG1Y1ED0Y
Molecule Type:
Small molecule
Molecular Formula:
C13H9Cl3N2O
Molecular Weight:
315.59
AlogP:
5.29
PSA:
41.13
HBD:
2.0
HBA:
#RotB:
2.0
Source:
ETAFEDRINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ETAFEDRINE
×
Maximum Phase:
4
First Approval:
None
UNII:
2Y6VQU63E8
Molecule Type:
Small molecule
Molecular Formula:
C12H19NO
Molecular Weight:
193.29
AlogP:
2.06
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
4.0
Source:
HYDROCORTISONE; POLYMYXIN B SULFATE
4
Combination
Approved
OTHER
OTIC
Unknown
Unknown
HYDROCORTISONE; POLYMYXIN B SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CITICOLINE
4
Small molecule
Approved
Unknown
Unknown
Ischemic Stroke; Marijuana Abuse; Amphetamine-Related Disorders; Attention Deficit Disorder with Hyperactivity; Brain Injuries; Brain Ischemia; Cerebral Infarction; Stroke
Unknown
CITICOLINE
×
Maximum Phase:
4
First Approval:
None
UNII:
536BQ2JVC7
Molecule Type:
Small molecule
Molecular Formula:
C14H26N4O11P2
Molecular Weight:
488.33
AlogP:
-2.23
PSA:
215.72
HBD:
4.0
HBA:
#RotB:
10.0
Source:
EPTINEZUMAB-JJMR
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
EPTINEZUMAB-JJMR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PIVAMPICILLIN
4
Small molecule
Approved
Unknown
Unknown
Bacterial Infections
Bacterial penicillin-binding protein inhibitor
PIVAMPICILLIN
×
Maximum Phase:
4
First Approval:
None
UNII:
0HLM346LL7
Molecule Type:
Small molecule
Molecular Formula:
C22H29N3O6S
Molecular Weight:
463.56
AlogP:
1.32
PSA:
128.03
HBD:
2.0
HBA:
#RotB:
6.0
Source:
QUINESTRADOL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
QUINESTRADOL
×
Maximum Phase:
4
First Approval:
None
UNII:
422L8173W8
Molecule Type:
Small molecule
Molecular Formula:
C23H32O3
Molecular Weight:
356.51
AlogP:
4.2
PSA:
49.69
HBD:
2.0
HBA:
#RotB:
2.0
Source:
TAGRAXOFUSP-ERZS
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TAGRAXOFUSP-ERZS
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
THIMEROSAL
4
Small molecule
Approved
Unknown
Unknown
Hepatitis B, Chronic
Antimicrobial preservative, used in vaccines
THIMEROSAL
×
Maximum Phase:
4
First Approval:
None
UNII:
2225PI3MOV
Molecule Type:
Small molecule
Molecular Formula:
C9H9HgNaO2S
Molecular Weight:
404.82
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SODIUM SULFATE;POTASSIUM SULFATE;MAGNESIUM SULFATE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
SODIUM SULFATE;POTASSIUM SULFATE;MAGNESIUM SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INSULIN RECOMBINANT HUMAN
4
Unknown
Approved
Unknown
INJECTION
Unknown
Unknown
INSULIN RECOMBINANT HUMAN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FILGRASTIM-AAFI
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
FILGRASTIM-AAFI
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LATANOPROST; NETARSUDIL DIMESYLATE
4
Combination
Approved
Unknown
OPHTHALMIC
Unknown
Unknown
LATANOPROST; NETARSUDIL DIMESYLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHYSOSTIGMINE SALICYLATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Acetylcholinesterase inhibitor
PHYSOSTIGMINE SALICYLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
2046ZRO9VU
Molecule Type:
Small molecule
Molecular Formula:
C22H27N3O5
Molecular Weight:
413.47
AlogP:
1.77
PSA:
44.81
HBD:
1.0
HBA:
#RotB:
1.0
Source:
PROMESTRIENE
4
Small molecule
Approved
Unknown
Unknown
Hypospadias
Unknown
PROMESTRIENE
×
Maximum Phase:
4
First Approval:
None
UNII:
GXM4PER6WZ
Molecule Type:
Small molecule
Molecular Formula:
C22H32O2
Molecular Weight:
328.5
AlogP:
5.35
PSA:
18.46
HBD:
0.0
HBA:
#RotB:
4.0
Source:
NEOMYCIN SULFATE; PREDNISOLONE ACETATE
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
NEOMYCIN SULFATE; PREDNISOLONE ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
4
Combination
Approved
Unknown
TOPICAL
Unknown
Unknown
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BOTULINUM TOXIN
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
BOTULINUM TOXIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEVOMEPROMAZINE HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
LEVOMEPROMAZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
42BB1Y2586
Molecule Type:
Small molecule
Molecular Formula:
C19H25ClN2OS
Molecular Weight:
364.94
AlogP:
4.5
PSA:
15.71
HBD:
0.0
HBA:
#RotB:
5.0
Source:
1
2
…
302
303
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA